title: [Comparative changes in PaO2 in moderately hypoxemic COPD patients treated with almitrine versus placebo for one year].
authors.affiliation: Department of Respiratory Medicine, Institute of Tuberculosis and Lung Diseases, Polska, Varsovie, Pologne.
authors.forename: D
authors.initials: D
authors.lastname: Górecka
authors.forename: P
authors.initials: P
authors.lastname: Sliwinski
authors.forename: G
authors.initials: G
authors.lastname: Palasiewicz
authors.forename: R
authors.initials: R
authors.lastname: Pachocki
authors.forename: J
authors.initials: J
authors.lastname: Zielinski
mesh_terms: D000368:Aged; D015765:Almitrine / Q000494:pharmacology*; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood*; D010919:Placebos; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D019141:Respiratory System Agents / Q000494:pharmacology*; D016896:Treatment Outcome
chemical_list: D010919:Placebos; D019141:Respiratory System Agents; D015765:Almitrine; D010100:Oxygen
vernacular_title: Evolution comparative de la PaO2 chez des patients BPCO modérément hypoxémiques traités par almitrine versus placebo pendant un an.